Incannex Healthcare (IXHL) Fundamental Analysis: Revenue, Earnings & Valuation

3.94 / 10

Netural

Fundamentals rate Neutral with a 3.9/10 score, indicating poor condition. Strengths include accounts receivable and fixed‑asset turnover; weaknesses are zero income‑tax ratio and low PB‑ROE. Overall, the financial health is guarded.

Analysis Checks(8/10)

Revenue-MV

Value-0.08

Score3/3

Weight44.20%

1M Return8.83%

Total operating revenue (YoY growth rate %)

Value616.67

Score2/3

Weight2.35%

1M Return0.58%

Inventory turnover ratio

Value106.57

Score3/3

Weight-2.51%

1M Return-0.67%

Accounts receivable turnover ratio

Value23.61

Score2/3

Weight-2.49%

1M Return-0.65%

PB-ROE

Value-0.24

Score0/3

Weight18.17%

1M Return3.80%

Income tax / Total profit (%)

Value0.00

Score0/3

Weight-5.65%

1M Return-1.54%

Fixed assets turnover ratio

Value0.25

Score2/3

Weight-3.96%

1M Return-1.01%

Interest coverage ratio (EBIT / Interest expense) (%)

Value34.91

Score2/3

Weight-2.80%

1M Return-0.73%

Cost of sales ratio (%)

Value57.03

Score2/3

Weight-2.75%

1M Return-0.74%

Asset-MV

Value-0.55

Score2/3

Weight55.45%

1M Return9.91%

Is IXHL fundamentally strong?

IXHL scores 3.94/10 on fundamentals and holds a Fair valuation at present. Backed by its -29.79% ROE, 0.00% net margin, -0.93 P/E ratio, 0.62 P/B ratio, and 47.89% earnings growth, these metrics solidify its Netural investment rating.